Healthcare Triangle is trading 11.03% down at $0.43 as uncertainty persists over its Nasdaq delisting appeal.
- Nasdaq issued a delisting determination for failure to meet the $1.00 minimum bid-price rule; Healthcare Triangle was ineligible for the normal compliance period.
- The company intended to request a hearing by October 8, which would stay suspension. Its filing does not confirm submission or provide an October 12 status update.
- This points to company-specific listing risk, not a broad-market explanation.